ARCHIMED sells a majority stake in Ad-Tech to Nihon Kohden, yielding a 5x return on investment while entering a strategic joint-venture for growth in key markets.

Information on the Target

Ad-Tech is a notable entity within the medical technology sector, recognized for its innovative contributions to electronic medical devices. The company specializes in the development and distribution of advanced solutions that enhance medical procedural efficiency and patient outcomes. With a commitment to cutting-edge technology and robust product offerings, Ad-Tech has secured a significant market presence internationally.

By leveraging its core capabilities, Ad-Tech has not only expanded its product lines but also established itself as a pivotal player in the medical electronic equipment space. The recent investment has catalyzed further enhancements and expansions, positioning the company for sustained success in various global markets.

Industry Overview in Japan

The medical technology industry in Japan is one of the most advanced globally, characterized by continuous innovation and significant investment in research and development. As one of the largest markets for me

View Source

Similar Deals

永昕生醫 Alfresa

2025

Joint Venture Biopharmaceuticals Japan
永昕生醫 Alfenax Biologic Corporation

2025

Joint Venture Biopharmaceuticals Japan
武田薬品工業株式会社 株式会社Veritas In Silico

2024

Joint Venture Proprietary & Advanced Pharmaceuticals Japan
メディアスホールディングス 共栄医科器械

2026

Buyout Medical Equipment, Supplies & Distribution (NEC) Japan
ルネサンス マイリハ

2026

Other Residential & Long-Term Care Japan

Nihon Kohden

invested in

Ad-Tech

in 2023

in a Joint Venture deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert